Rising concerns about current malaria treatments For decades, artemisinin-based combination therapies (ACTs) have been the backbone of malaria treatment, delivering rapid symptom control and reducing transmission when used correctly. Yet scientists have warned that the long, heavy demand on these drugs—paired with evolving resistance—could undermine a global progress milestone. In regions where resistance has crept…